AbCellera Biologics (ABCL) Q4 2023 Earnings Call Transcript

ABCL earnings call for the period ending December 31, 2023.

Related Keywords

United States ,Canada ,United Kingdom ,America ,British ,Canadian ,Robyn Karnauskas ,Piper Sandler ,Puneet Souda ,Robyn Karnauskas Truist ,Abcellera Biologics ,Carl Hansen ,Evan Seigerman ,Steve Willey ,Steve Dechert ,Tryn Stimart ,Allison Bratzel Piper Sandler ,Allison Bratzel ,Steven Mah ,Steve Dechert Keybanc ,Goldman Sachs ,Amgen ,Canada Strategic Innovation Fund ,Abcellera Biologics Inc ,Keycorp ,Exchange Commission ,Steve Willey Stifel Financial Corp ,Andrew Booth ,Safe Harbor ,Private Securities Litigation Reform Act ,Motley Fool Stock Advisor ,Stock Advisor ,Chief Executive ,British Columbia ,Arsenal Bio ,Trianni Mouse ,Strategic Innovation ,Andrea Tan ,Maybei Ll ,Banc Capital Markets ,Stifel Financial ,Keybanc Capital Markets ,Chief Executive Officer ,Thanks Andrea ,Clinical Development ,Arsenal ,